[Webinar] In this session, Dr. Sam Taylor will discuss the latest developments in feline disease management, including how caregivers can support their pets through the treatment process.
[Useful download] Home care and monitoring are an essential part of caring for your cat, when diagnosed with Feline Infectious Peritonitis (FIP). This diary is designed to help you effectively monitor your cat’s condition between veterinary visits, as well as provide valuable insights to your veterinary surgeon.
[Webinar] Join us for an essential webinar tailored for veterinary surgeons grappling with the intricacies of diagnosing and treating Feline Infectious Peritonitis (FIP). Led by esteemed expert Sam Taylor, RCVS Recognised Specialist in Feline Medicine, this webinar will highlight the key clinical abnormalities indicative of FIP, decode lab findings, and address the important question of when treatment trials are appropriate.
[Webinar] The last few years have seen an explosion in our knowledge of treating FIP but where have we landed in terms of drugs, dosage and prognosis?
[Useful resource] Gain a comprehensive understanding of Feline Infectious Peritonitis (FIP), including its causes, symptoms, diagnosis, available treatments, and how to support cats during and after treatment.
Learn about the growing experience in treating FIP (Feline Infectious Peritonitis) with antiviral drugs in 2024 from leading specialists, offering valuable insights for veterinary professionals.
In a VETchat episode, Professor Danielle Gunn-Moore discussed feline medicine, focusing on mycobacterium and feline infectious peritonitis (FIP). They addressed the current outbreak of FIP in Cyprus and the emergence of the FCoV-23 variant found in cats of all ages. Gunn-Moore emphasized the improved treatment for mycobacterium and the need for proactive measures against FCoV-23.
Advances in FIP treatment, an Australia perspective (2021) Overview Advances in anti-viral therapy are showing that effective treatment for FIP is finally now a reality. Since 2018, publications emerged showing FIP remission states were being achieved with new antiviral compounds. Registered, commercial options remain unavailable, however, vets are now gaining legal access to the nucleoside analogue remdesivir via BOVA compounding pharmacy. Preliminary…